MMJ Marijuana DEA Grow Approval Imminent, Biden Signs Marijuana Research Law – World News ReportPosted by On

Researchers can only obtain product for research from DEA approved schedule 1 registrants.

PROVIDENCE, RI / ACCESSWIRE / December 2, 2022 / MMJ International Holdings, MMJ BioPharma Cultivation, and MMJ BioPharma Labs is pleased to announce that President Joe Biden has officially signed a marijuana research bill into law. After seven long years of waiting, this law will facilitate the MMJ group of companies to complete its mission of conducting its clinical trials in Multiple Sclerosis and Huntington’s Disease. MMJ has been awarded a FDA Orphan Designation for its Huntington’s clinical trials.

More specifically, the bill directs the Drug Enforcement Administration (DEA) to follow specified procedures to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research. The bill will allow the MMJ entities to manufacture, distribute, dispense, or possess marijuana (THC) or cannabidiol (CBD) for the purposes of medical research.

The bill further mandates that the U.S. attorney general will have 60 days to either approve a given application or request supplemental information from the marijuana research applicant. It also creates a more efficient pathway for MMJ researchers to request larger quantities of cannabis.

Dr. Elio Mariani the…

Original Author Link click here to read complete story..



Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.